Publications

Lozano, J.M. & Muller, S. (2023) Monkeypox: Potential vaccine development strategies. Trends Pharmacol Sci, in press

Galvão, I., Mastrippolito, D., Talamini, L., Aganetti, M., Rocha, V., Verdot, C., Mendes, V., Soares De Oliveira, V.L., Dias Braga, A., Dantas, V., Caetano Faria, A.M., Almeida Amaral, F., Georgel, P., Vieira, A.T.  & Muller, S. (2022) The therapeutic effect of phosphopeptide P140 attenuates inflammation induced by uric acid crystals in gout arthritis mouse model. Cells 11, 3709

Thurner, L., Fadle, N., Regitz, E., Preuss, K.-D., Neumann, F., Cetin, O., Schormann, C., Hoffmann, M.C., Herr, C., Kheirodin, P., Millard Rixecker, T., Bals, R., Muller, S., Thurner, B., Kessel, C., Kabesch, M., Bewarder, M., Heyne, K., Lensch C. & Age Kos I. (2022) Autoantibodies against SUMO1-DHX35 in long-COVID. J. Transl. Autoimmun. 5, 100171

Akiyama, K., Aung, K.T., Talamini, L., Huck, O., Kuboki, T. & Muller, S. (2022) Therapeutic effects of peptide P140 in a mouse periodontitis model. Cell. Mol. Life Sci, 79:518. DOI : 10.1007/s00018-022-04537-2

Schall, N., Talamini, L., Wilhelm, M., Jouvin-Marche, E. & Muller, S. (2022) P140 peptide leads to clearance of autoreactive lymphocytes and normalizes immune response in lupus-prone mice. Front. Immunol. 13:904669. doi

Retnakumar, S.V., Geesala, R., Bretin, A., Tourneur-Marsille, J., Ogier-Denis, E., Maretzky, T., Nguyen, H.T.T & Muller, S. (2022) Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases. J. Autoimmunity 128:102814

Brun, S., De Sèze, J. & Muller, S. (2022). CIDP: Current treatments and identification of targets for future specific therapeutic intervention. Immuno 2, 118-131.

Srinivasa Reddy Bonam, Christine Tranchant and Sylviane Muller (2021). Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease . Cells 10, 3547.

Schall, N., Daubeuf, F., Marsol, C. Frossard, N., Bonnet D., Galzi, J.-L. Muller, S. (2021). A selective neutraligand for CXCL12/SDF-1a with beneficial regulatory functions in MRL/lpr lupus prone mice. Front Pharmacol 12, 752194. doi.org/10.3389/fphar.2021.752194

Daubeuf F, Schall N, Petit-Demoulière N, Frossard N, Muller S (2021). An autophagy modulator peptide prevents lung function decrease and corrects established inflammation in murine models of airway allergy. Cells 10(9):2468. doi: 10.3390/cells10092468.

Rafiq S, McKenna SL, Muller S, Tschan MP, Humbert M (2021). Lysosomes in acute myeloid leukemia: potential therapeutic targets? Leukemia. doi: 10.1038/s41375-021-01388-x.

Wilhelm M, Bonam SR, Schall N, Bendorius M, Korganow AA, Lumbroso C, Muller S (2021). Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus. J Autoimmunity 120:102633. doi: 10.1016/j.jaut.2021.102633.

Dotan A, Kanduc D, Muller S, Makatsariya A, Shoenfeld Y (2021). Molecular mimicry between SARS-CoV-2 and the female reproductive system. Am J Reprod Immunol 10.1111/aji.13494. doi: 10.1111/aji.13494.

Talamini L, Matsuura E, De Cola L, Muller S (2021). Immunologically inert nanostructures as selective therapeutic tools in inflammatory diseases. Cells 10(3):707. doi: 10.3390/cells10030707.

Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y (2021). The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmunity Rev 20(4):102792. doi: 10.1016/j.autrev.2021.102792.

Klionsky DJ et al. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy 8:1-382.

Bonam SR, Muller S (2020). Parkinson’s disease is an autoimmune disease: a reappraisal. Autoimmunity Rev 19(12):102684. doi: 10.1016/j.autrev.2020.102684.

Wang F, Tasset I, Cuervo AM, Muller S (2020). In vivo remodeling of altered autophagy-lysosomal pathway by a phosphopeptide in lupus. Cells 9(10):2328. doi: 10.3390/cells9102328.

Bonam SR, Muller S, Bayry J, Klionsky DJ (2020). Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. Autophagy 16(12):2260-2266. doi: 10.1080/15548627.2020.1779467.

Narasaraju T, Tang BM, Herrmann M, Muller S, Chow VTK, Radic M (2020). Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19. Frontiers in Pharmacology 11:870.

Voynova E, Lefebvre F, Qadri A, Muller S (2020). Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome. J of Autoimmunity 108:102418. doi: 10.1016/j.jaut.2020.102418

Bonam SR, Tschan MP, Bayry J, Muller S (2020). Progress and challenges in the use of MAP1LC3 as a legitimate marker for measuring dynamic autophagy in vivo. Cells 9(5):1321. doi: 10.3390/cells9051321.

Bonam SR, Areti A, Komirishetty P, Muller S (2020). Dendrimers in immunotherapy and hormone therapy in Pharmaceutical applications of dendrimers; chapter 10, pp 233-249. Abhay Chauhan and Hitesh Kulhari (Eds) Elsevier.

Bonam SR, Ruff M, Muller S (2019). HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates. Cells 8:849.

Retnakumar SV, Muller S (2019). Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends Mol Med. 25:516-537.

Bonam SR, Bhunia D, Muller S, Nerella SG, Alvala M, Halmuthur Mahabalarao SK (2019). Novel trisaccharide based phospholipids as immunomodulators. Int Immunopharmacol 74:105684.

Bonam SR, Wang F, Muller S (2019). Lysosomes as a therapeutic target. Nat Rev Drug Discovery 18:923-948.

Arbogast F, Arnold J, Hammann P, Kuhn L, Chicher J, Murera D, Weishaar J, Muller S, Fauny JD, Gros F (2019). ATG5 is required for B cell polarization and presentation of particulate antigens. Autophagy 15:280-294.

Bendorius M, Po C, Muller S, Jeltsch-David H (2018). From systemic inflammation to neuroinflammation: the case of neurolupus. Int J Mol Sci 19:3588.

Bonam SR, Wang F, Muller S (2018). Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. Journal of Autoimmunity 94:16-32.

Bendorius M, Neeli I, Wang F, Bonam SR, Dombi E, Buron N, Borgne-Sanchez A, Poulton J, Radic M, Muller S (2018). The mitochondrion-lysosome axis in adaptive and innate immunity: Effect of lupus regulator peptide P140 on mitochondria autophagy and NETosis. Front Immunol 9:2158.

Bonam SR, Wu YS, Tunki L, Chellian R, Kumar Halmuthur MS, Muller S, and Pandy V (2018). What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer? ChemMedChem 13:1854-1872.

Brun S, Schall N, Bonam SR, Bigauta K, Mensah-Nyagana AG, de Sèze J, Muller S (2018). An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies.

BERMÚDEZ, M., ARÉVALO-PINZÓN, G., RUBIO, L., CHALOIN, O., MULLER, S., CURTIDOR, H. & PATARROYO, M.A. (2018).Receptor-ligand and parasite protein-protein interactions in Plasmodium vivax: analysing rhoptry neck proteins 2 and 4. Cell. Microbiol. 20, e12835

KÖKTEN, T., GIBOT, S., LEPAGE, P., D’ALESSIO, S., HABLOT, J., NDIAYE, N.-C., BUSBY-VENNER, H., MONOT, C., GARNIER, B., MOULIN, D., JOUZEAU, J.-Y., HANSMANNEL, F., DANESE, S., GUÉANT, J.-L., MULLER, S. & PEYRIN-       BIROULET, L. (2018). TREM-1 inhibition restores impaired autophagy activity and reduces colitis in mice. J. Crohn Colitis 2018, 230-244

LI, B., WANG, F., SCHALL, N. & MULLER, S. (2018). Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide. J. Autoimmunity 90, 132-145

MURERA, D., ARBOGAST, F., ARNOLD, J., BOUIS, D., MULLER, S. & GROS, F. (2018). CD4 T cell autophagy is integral to memory maintenance. Sci. Rep. 8, 5951

WANG, F., BONAM, S.R, SCHALL, N., KUHN, L., HAMMANN, P., CHALOIN, O., MADINIER, J.-B., BRIAND, J.-P., PAGE, N. & MULLER, S. (2018). Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival. Sci. Rep. 8, 16820

WILHELM, M., WANG, F., SCHALL, N., KLEINMANN, J.-F., FALUDI, M., NASHI, E.P., SIBILIA, J., MARTIN, T., SCHAEFFER, E. & MULLER, S. (2018). Lupus regulator peptide P140 represses B-cell antigen differentiation by reducing HLA class II overexpression. Arthritis Rheum 70, 1077-1088

MULLER, S. (2018). Excipients: not so inert? When the excipient plays the role of an active substance, as exemplified in systemic lupus. Swiss Med Wkly 148, w14631